- CEO
- Adam Rawlinson Binns
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Sheffield United Kingdom
- Business
- One Health Group PLC is a United Kingdom-based independent healthcare provider delivering National Health Service (NHS) funded elective surgical and diagnostic care. Founded in 2001 and headquartered in Sheffield, South Yorkshire, the company operates under the NHS Patient Choice framework, enabling patients referred through the NHS e-Referral Service (e-RS) to access consultant-led consultations and surgical treatments free at the point of delivery.
The company delivers surgical and medical solutions across five core specialties: Orthopaedics, including hip, knee, and shoulder joint replacements, arthroscopic procedures, and peripheral joint repairs; Spinal Surgery, including lumbar decompressions, discectomies, microdiscectomies, and spinal injections; General Surgery, including laparoscopic hernia repairs, cholecystectomies, upper gastrointestinal procedures, and colorectal treatments; Gynaecology, including operative and diagnostic hysteroscopies, laparoscopies, pelvic floor repairs, and minor gynaecological interventions; and Urology, encompassing diagnostic assessments and surgical treatments for urinary tract, bladder, and prostate conditions. In addition to surgical procedures, the group provides comprehensive perioperative pathways comprising initial outpatient consultations; diagnostic imaging coordination; post-operative follow-up reviews; and outpatient physiotherapy and musculoskeletal rehabilitation.
One Health Group PLC operates a distributed care delivery model, hosting initial consultations, diagnostics, and recovery care across a regional network of community outreach clinics while conducting surgical operations in partner independent hospital facilities, supported by an accredited network of NHS-affiliated consultant surgeons and anaesthetists. The company primarily serves NHS integrated care boards and patients throughout Yorkshire, Derbyshire, Nottinghamshire, Lincolnshire, Leicestershire, and Humberside.
Recent corporate developments include the transfer of the company's public listing from the Aquis Stock Exchange to the AIM market of the London Stock Exchange in March 2025, accompanied by a 7.8 million gross pound capital raise to fund capacity expansion. To scale operating capacity beyond third-party hospital partnerships, the group launched a dedicated surgical hub strategy, securing land in Scunthorpe, Lincolnshire for the construction of its first proprietary surgical facility. In addition, the company expanded its clinical portfolio by formally introducing Urology as a fifth core specialty to address regional elective care backlogs.